On February 17, 2023, the Federal Court ruled that Sandoz and Sun Pharma may counterclaim as of right against non-asserted patent claims in separate actions pursuant to the Patented Medicines (Notice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback